Cargando…
Cross-Talk between p53 and Wnt Signaling in Cancer
Targeting cancer hallmarks is a cardinal strategy to improve antineoplastic treatment. However, cross-talk between signaling pathways and key oncogenic processes frequently convey resistance to targeted therapies. The p53 and Wnt pathway play vital roles for the biology of many tumors, as they are c...
Autores principales: | Xiao, Qiyun, Werner, Johannes, Venkatachalam, Nachiyappan, Boonekamp, Kim E., Ebert, Matthias P., Zhan, Tianzuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946298/ https://www.ncbi.nlm.nih.gov/pubmed/35327645 http://dx.doi.org/10.3390/biom12030453 |
Ejemplares similares
-
Predicting response to neoadjuvant chemoradiotherapy in rectal
cancer: from biomarkers to tumor models
por: Li, Moying, et al.
Publicado: (2022) -
The Roles of Secreted Wnt Ligands in Cancer
por: Werner, Johannes, et al.
Publicado: (2023) -
Cross-Talk between Wnt Signaling and Src Tyrosine Kinase
por: Min, Jung Ki, et al.
Publicado: (2022) -
Cross-talk between Myc and p53 in B-cell lymphomas
por: Yu, Li, et al.
Publicado: (2019) -
Cross-Talk between Wnt and Hh Signaling Pathways in the Pathology of Basal Cell Carcinoma
por: Noubissi, Felicite K., et al.
Publicado: (2018)